BioSpace News Archive

Health Decisions, Inc., a full-service contract research organization specializing in women’s health clinical research and diagnostic development, announced that it has been retained as the Statistical and Clinical Coordinating Center (SCCC) for the Contraceptive Clinical Trials Network (CCTN) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a unit of the National Institutes of Health (NIH).

Dairy Council of California, a quasi-state government nutrition education organization committed to elevating the health and wellness of children and families, announced its fourth grade Nutrition Pathfinders program was accepted as a Research-Tested Intervention Program (RTIP) by the National Cancer Institute.

Leading researchers and physicians will present results from 20 clinical trials that focus on vascular interventional technology and treatment solutions on Tuesday, November 5, and Wednesday, November 6, at the VIVA conference at Wynn Las Vegas.

Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that treatment with ACE-083 in patients with facioscapulohumeral muscular dystrophy (FSHD) did not achieve functional secondary endpoints in the Phase 2 trial.

The National Alliance of Wound Care and Ostomy® (NAWCO®) launched the first professional credential to recognize clinical expertise in advanced wound care at the 2019 Wild On Wounds® (WOW®) national conference in Las Vegas.

The Catalight Foundation, a new non-profit organization headquartered in Walnut Creek, California, launched